scispace - formally typeset
Open AccessJournal ArticleDOI

H-2D control of recovery from Friend virus leukemia: H-2D region influences the kinetics of the T lymphocyte response to Friend virus.

William J. Britt, +1 more
- 01 Jun 1983 - 
- Vol. 157, Iss: 6, pp 1736-1745
TLDR
No evidence for nonspecific immunosuppression of the T lymphocyte response to concanavalin A was observed in any of the H-2 congenic F1 mice studied, supported by the ability of passively transferred immune splenic T lymphocytes to induce recovery from leukemia at 6 d after FV inoculation, but not at 16 d.
Abstract: 
A Friend virus (FV)-specific T lymphocyte proliferation assay was used to compare the T lymphocyte responses of H-2 congenic mice that differed in their ability to recover from FV leukemia after inoculation of high virus doses. Gene(s) of the H-2D region influenced the kinetics of this response such that H-2Db/b homozygous mice were positive 6-8 d earlier than H-2Dd/b mice. This correlated with the Rfv-1, H-2D-linked influence on recovery from FV by these mice, and also appeared to explain the prominent effect of virus dose on recovery incidence. These findings were supported by the ability of passively transferred immune splenic T lymphocytes to induce recovery from leukemia at 6 d after FV inoculation, but not at 16 d. H-2a/a mice were found to be unresponsive in the FV-specific T lymphocyte proliferation assay. This effect mapped to the left of H-2D, possibly in the H-2I region, and may be an in vitro manifestation of the Rfv-2 gene. No evidence for nonspecific immunosuppression of the T lymphocyte response to concanavalin A was observed in any of the H-2 congenic F1 mice studied.

read more

Citations
More filters
Journal ArticleDOI

Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity.

TL;DR: A quantitative focal immunoassay for HIV was developed using human HeLa cells rendered susceptible to HIV infection by introduction of the CD4 gene via a retrovirus vector, and two monoclonal antibodies reactive with HIV gp120 were found to neutralize only the LAV-IIIB strain of HIV.
Journal ArticleDOI

Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations.

TL;DR: Strikingly, Th and Tc cooperate in anti-Sendai virus immunity, since permanent survival of lethally infected nu/nu mice was only achieved by inoculation of a mixture of Tc and Th clones or a combination of a Tc clone and rIL-2.
Journal ArticleDOI

T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.

TL;DR: Mice inoculated with live recombinant vaccinia virus had an envelope-specific T-cell proliferative response and, after challenge with Friend virus complex, developed neutralizing antibody and cytotoxic T cells (CTL) and were protected against leukemia.
Journal ArticleDOI

Apobec3 Encodes Rfv3, a Gene Influencing Neutralizing Antibody Control of Retrovirus Infection

TL;DR: It is demonstrated that Rfv3 is encoded by Apobec3, a single autosomal gene encoding a resistance trait that influences retroviral neutralizing antibody responses and viremia that has broad inhibitory activity against retroviruses, including HIV.
Journal ArticleDOI

Immunity to retroviral infection: The Friend virus model

TL;DR: The genetics of immune resistance and the types of immune responses required for recovery from infection are reviewed, as is a non-MHC gene, Rfv-3, which controls virus-specific antibody responses.
References
More filters
Book ChapterDOI

MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

TL;DR: This chapter focuses on the important discovery that virus-specific cytotoxic T cells are dually specific for virus and for a self cell surface antigen encoded by the major histocompatibility complex (MHC).
Book ChapterDOI

The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization.

TL;DR: This chapter discusses the immune response region, the genes of which appear to control a variety of immune phenomena—including antibody response to many antigens, susceptibility to tumor viruses, and graft-versus-host (GVH), and mixed lymphocyte culture (MLC) reactions.
Book ChapterDOI

Immunodepression and malignancy.

TL;DR: Both clinical and experimental evidence indicates that the diseases or procedures that lower the immune functions in mammals are associated with a higher incidence of malignancies.
Journal ArticleDOI

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

TL;DR: The phenotype of T cells therapeutically effective in immunotherapy of advanced Friend virus-induced FBL leukemia in vivo and cytotoxic to FBL in vitro was determined and potentially, the Lyt-1+2- cell may operate in vivo as an amplifier cell rather than by a direct anti-tumor effect.
Journal ArticleDOI

HOST GENETIC CONTROL OF RECOVERY FROM FRIEND LEUKEMIA VIRUS-INDUCED SPLENOMEGALY Mapping of a Gene Within the Major Histocompatability Complex

TL;DR: In mice with recombinations within the H-2 complex a gene (designated RFV-1), responsible for the Friend virus recovery effect, was found to map near or within the D region of serologically detectable transplantation antigens.
Related Papers (5)